Carr Financial Group Corp Astrazeneca PLC Transaction History
Carr Financial Group Corp
- $322 Billion
- Q4 2024
A detailed history of Carr Financial Group Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Carr Financial Group Corp holds 3,063 shares of AZN stock, worth $227,335. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,063
Previous 3,063
-0.0%
Holding current value
$227,335
Previous $239 Million
15.9%
% of portfolio
0.06%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...